Century Lithium Corp. announced plans to build a commercial-scale chlor-alkali plant to support its Angel Island Lithium Project in Nevada and the broader critical minerals supply chain in the western US. The plant aims to produce chlorine, hydrochloric acid, and sodium hydroxide, with an initial capacity of 300 short tons per day of chlorine, potentially doubling based on demand. The company has signed eight non-binding memoranda of understanding for offtake and is finalizing site selection in Nevada or Utah. Financing will be sought through non-dilutive project-level methods, including vendor financing, institutional equity, and US government programs, with no costs added to the Angel Island project itself.
Century Lithium's plan for a chlor-alkali plant provides context for readers interested in basic materials. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Sep 22, 2026 21:21 WIB: out of 38 priced US stocks, 30 rose and 8 fell. Air Products & Chemicals (APD) rose 1.66% to USD 284.09 with a typical hold time of 59 days, while WD 40 Company (WDFC) increased 1.25% to USD 193.93 but saw 100% sell orders and a shorter hold time of 21 days. Barrick Gold Corp (B) gained 1.21% to USD 43.20 with 100% buy orders and a typical hold time of 54 days.
MillerKnoll reported a strong Q1 2027 earnings per share (EPS) of $0.53, surpassing analyst expectations by over 51%, helped by tariff refunds and improved cost management. However, its revenue fell 3.4% year-over-year to $923.40 million, missing est...
THOR Industries reported Q4 earnings with an EPS of $0.78, missing analyst estimates and showing a 66.9% drop from last year. Despite this, the company beat revenue expectations with $2.31 billion, though revenue declined 8.4% year-over-year due to w...
Cracker Barrel Old Country Store is set to report its Q3 2026 earnings on September 23, with analysts predicting a significant decline. Earnings per share are expected to fall to $0.17 from $0.74 last year, and revenue is forecasted around $834.57 mi...
Abivax received positive pre-NDA feedback from the U.S. FDA for its drug Obefazimod, marking a key step in its development. Despite a recent price target cut by Wedbush to $118, analysts maintain a "Moderate Buy" consensus with an average target of $...
HSBC and Wells Fargo have downgraded Netflix stock due to declining subscriber engagement and an 8% drop in viewership time. Despite a recent 2.19% stock gain, Netflix shares have fallen over 40% in the past year amid strong competition and weaker or...
